Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitroglycerin with Chemotherapy in Stage IV Non-Squamous NSCLC
NCT01171170Phase 2Completed
- Sponsor
- NVALT
- Start
- Jan 2011
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of nitroglycerin in Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC) (2 arms), sponsored by NVALT. Primary endpoint: Progression Free Survival. Started Jan 2011; status: completed.
02
Drugs
nitroglycerin
03
Conditions
Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC)
Beyond the preview
Go deeper on NCT01171170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01171170.